109 related articles for article (PubMed ID: 21986584)
21. Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
Zampieri D; Mamolo MG; Laurini E; Florio C; Zanette C; Fermeglia M; Posocco P; Paneni MS; Pricl S; Vio L
J Med Chem; 2009 Sep; 52(17):5380-93. PubMed ID: 19673530
[TBL] [Abstract][Full Text] [Related]
22. Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations.
Gund TM; Floyd J; Jung D
J Mol Graph Model; 2004 Jan; 22(3):221-30. PubMed ID: 14629980
[TBL] [Abstract][Full Text] [Related]
23. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
[TBL] [Abstract][Full Text] [Related]
24. Oxa-Pictet-Spengler reaction as key step in the synthesis of novel σ receptor ligands with 2-benzopyran structure.
Knappmann I; Schepmann D; Wünsch B
Bioorg Med Chem; 2016 Sep; 24(18):4045-4055. PubMed ID: 27396684
[TBL] [Abstract][Full Text] [Related]
25. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
Laggner C; Schieferer C; Fiechtner B; Poles G; Hoffmann RD; Glossmann H; Langer T; Moebius FF
J Med Chem; 2005 Jul; 48(15):4754-64. PubMed ID: 16033255
[TBL] [Abstract][Full Text] [Related]
26. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.
Silvestri R; Cascio MG; La Regina G; Piscitelli F; Lavecchia A; Brizzi A; Pasquini S; Botta M; Novellino E; Di Marzo V; Corelli F
J Med Chem; 2008 Mar; 51(6):1560-76. PubMed ID: 18293908
[TBL] [Abstract][Full Text] [Related]
28. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
Manallack DT; Wong MG; Costa M; Andrews PR; Beart PM
Mol Pharmacol; 1988 Dec; 34(6):863-79. PubMed ID: 2849051
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and pharmacological evaluation of some 2-[4-morpholino]-3-aryl-5-substituted thiophenes as novel anti-inflammatory agents: generation of a novel anti-inflammatory pharmacophore.
Pillai AD; Rathod PD; Xavier FP; Vasu KK; Padh H; Sudarsanam V
Bioorg Med Chem; 2004 Sep; 12(17):4667-71. PubMed ID: 15358292
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of conformationally restricted σ(1) receptor ligands with 7,9-diazabicyclo[4.2.2]decane scaffold.
Sunnam SK; Schepmann D; Rack E; Fröhlich R; Korpis K; Bednarski PJ; Wünsch B
Org Biomol Chem; 2010 Dec; 8(24):5525-40. PubMed ID: 20953473
[TBL] [Abstract][Full Text] [Related]
32. Structure-Affinity Relationships of Fluorinated Spirocyclic σ
Bergkemper M; Kronenberg E; Schepmann D; Ludwig FA; Brust P; Wünsch B
ChemMedChem; 2019 Aug; 14(15):1392-1402. PubMed ID: 31189022
[TBL] [Abstract][Full Text] [Related]
33. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring.
Holl R; Jung B; Schepmann D; Humpf HU; Grünert R; Bednarski PJ; Englberger W; Wünsch B
ChemMedChem; 2009 Dec; 4(12):2111-22. PubMed ID: 19827086
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of thiophene-based TAK-779 analogues by C-H arylation.
Junker A; Yamaguchi J; Itami K; Wünsch B
J Org Chem; 2013 Jun; 78(11):5579-86. PubMed ID: 23642160
[TBL] [Abstract][Full Text] [Related]
36. Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity.
Torres-Gómez H; Daniliuc C; Schepmann D; Laurini E; Pricl S; Wünsch B
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073622
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of bridged piperazines with sigma receptor affinity.
Weigl M; Wünsch B
Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073
[TBL] [Abstract][Full Text] [Related]
38. Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.
Bedürftig S; Wünsch B
Bioorg Med Chem; 2004 Jun; 12(12):3299-311. PubMed ID: 15158798
[TBL] [Abstract][Full Text] [Related]
39. Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity.
Banister SD; Moussa IA; Jorgensen WT; Chua SW; Kassiou M
Bioorg Med Chem Lett; 2011 Jun; 21(12):3622-6. PubMed ID: 21555222
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]